SCHEMBL293148

SCHEMBL293148

COCCCOc1ccccc1N1CCNC(C)(C)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 7/20 0.43
DRD3 P35462 5/20 0.43
HTR3E A5X5Y0 1/20 0.43
HTR3B O95264 1/20 0.43
ADRB1 P08588 1/20 0.43
CYP2C19 P33261 1/20 0.43
HTR3A P46098 1/20 0.43
HTR6 P50406 1/20 0.43
HTR3D Q70Z44 1/20 0.43
HTR3C Q8WXA8 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
HTR1A P08908 3/20 0.41
SLC6A2 P23975 2/20 0.41
SLC6A4 P31645 2/20 0.41
SLC6A3 Q01959 1/20 0.41
REN P00797 1/20 0.39
HTR7 P34969 2/20 0.38
HTR2A P28223 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL291319 0.77 ADRB1 (0.44) DRD2ADRB1CYP2C19MAPTREN
SCHEMBL292789 0.76 REN (0.40) RENADRA1AKDM4EALDH1A1TDP1
SCHEMBL8141910 0.71 HTR3A (0.61) DRD2DRD3HTR3EHTR3BADRB1
SCHEMBL6023940 0.71 ADRA2C (0.49) DRD2DRD3HTR3EHTR3BADRB1
SCHEMBL292325 0.70 DRD2 (0.42) DRD2DRD3RENKDM4EALDH1A1
SCHEMBL292591 0.69 REN (0.39) RENADRA1AKDM4EALDH1A1TDP1
SCHEMBL20139950 0.69 DRD2 (0.40) DRD2DRD3ADRB1HTR1AHTR7
SCHEMBL9319475 0.69 HTR1A (0.62) DRD2DRD3HTR3EHTR3BADRB1
SCHEMBL9319232 0.68 HTR1A (0.61) DRD2DRD3HTR3EHTR3BADRB1
SCHEMBL14661549 0.68 HTR3A (0.60) DRD2DRD3HTR3EHTR3BADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158790-B2 Cyclic amine compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-04-17 US disclosed
EP-2036896-B1 CYCLIC AMINE COMPOUND DAIICHI SANKYO CO LTD (JP) 2012-03-14 EP disclosed
US-20090286807-A1 CYCLIC AMINE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-11-19 US disclosed
EP-2036896-A1 CYCLIC AMINE COMPOUND Daiichi Sankyo Company, Limited (JP) 2009-03-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286807-A1 CYCLIC AMINE COMPOUND HRH3, HRH4, H1-0 DRD2 69/4885DRD3 71/4885HTR3E 254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.